Pharmacyclics, Inc.
PCYCDrugs in Pipeline
21
Phase 3 Programs
11
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Venetoclax
Mantle-Cell Lymphoma
Chlorambucil
Chronic Lymphocytic Leukemia
MGd
Metastatic Cancer
Gemcitabine
Metastatic Pancreatic Adenocarcinoma
Ibrutinib Oral Capsule
Follicular Lymphoma
Next-line ibrutinib
Chronic Lymphocytic Leukemia
Ibrutinib
Diffuse Large B Cell Lymphoma Relapsed
Prednisone
Chronic Graft Versus Host Disease
ofatumumab
B-cell Chronic Lymphocytic Leukemia
Motexafin Gadolinium
Brain Neoplasms
Obinutuzumab
Chronic Lymphocytic Leukemia
Bortezomib
Multiple Myeloma
Lenalidomide
Relapsed Diffuse Large B-Cell Lymphoma
PCI-24781
Lymphoma
MEDI4736
Diffuse Large B-Cell Lymphoma
everolimus
Metastatic Renal Cell Carcinoma
Motexafin Gadolinium Injection
Multiple Myeloma
PCI-27483
Pancreatic Cancer
PCI-32765
B-cell Chronic Lymphocytic Leukemia
Carfilzomib
Multiple Myeloma
Dexamethasone
Multiple Myeloma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Venetoclax | Phase 3 | Mantle-Cell Lymphoma | - | - |
Chlorambucil | Phase 3 | Chronic Lymphocytic Leukemia | - | - |
MGd | Phase 3 | Metastatic Cancer | - | - |
Gemcitabine | Phase 3 | Metastatic Pancreatic Adenocarcinoma | - | - |
Ibrutinib Oral Capsule | Phase 3 | Follicular Lymphoma | - | - |
Next-line ibrutinib | Phase 3 | Chronic Lymphocytic Leukemia | - | - |
Ibrutinib | Phase 3 | Diffuse Large B Cell Lymphoma Relapsed | - | - |
Prednisone | Phase 3 | Chronic Graft Versus Host Disease | - | - |
ofatumumab | Phase 3 | B-cell Chronic Lymphocytic Leukemia | - | - |
Motexafin Gadolinium | Phase 3 | Brain Neoplasms | - | - |
Obinutuzumab | Phase 3 | Chronic Lymphocytic Leukemia | - | - |
Bortezomib | Phase 2 | Multiple Myeloma | - | - |
Lenalidomide | Phase 2 | Relapsed Diffuse Large B-Cell Lymphoma | - | - |
PCI-24781 | Phase 2 | Lymphoma | - | - |
MEDI4736 | Phase 2 | Diffuse Large B-Cell Lymphoma | - | - |
everolimus | Phase 2 | Metastatic Renal Cell Carcinoma | - | - |
Motexafin Gadolinium Injection | Phase 2 | Multiple Myeloma | - | - |
PCI-27483 | Phase 2 | Pancreatic Cancer | - | - |
PCI-32765 | Phase 2 | B-cell Chronic Lymphocytic Leukemia | - | - |
Carfilzomib | Phase 2 | Multiple Myeloma | - | - |
Dexamethasone | Phase 2 | Multiple Myeloma | - | - |